Thyme Care
Humana Medicare Advantage members will have access to Thyme Care's oncology services 24/7, including nurses, nurse practitioners, social workers and resource specialists.
Thyme Care secures $60 million in Series B funding, and Neuspera Medical garners $23 million.
Dr. Julia Frydman will be the oncology-focused company's first medical director for palliative care. She will oversee its new Enhanced Supportive Care program.
The company will use the funds to expand its value-based cancer care network and extend its reach with health plans, employers and providers.